ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report)’s stock price crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $82.68 and traded as low as $78.60. ProShares Ultra Nasdaq Biotechnology shares last traded at $81.08, with a volume of 8,256 shares traded.
ProShares Ultra Nasdaq Biotechnology Trading Up 3.1%
The stock has a market cap of $75.40 million, a price-to-earnings ratio of 20.68 and a beta of 1.24. The stock’s 50 day moving average is $82.68 and its two-hundred day moving average is $82.39.
Institutional Trading of ProShares Ultra Nasdaq Biotechnology
A number of large investors have recently bought and sold shares of the business. Kaizen Financial Strategies boosted its stake in ProShares Ultra Nasdaq Biotechnology by 4.7% during the 1st quarter. Kaizen Financial Strategies now owns 5,565 shares of the exchange traded fund’s stock worth $483,000 after purchasing an additional 250 shares during the period. Citadel Advisors LLC acquired a new stake in ProShares Ultra Nasdaq Biotechnology during the 3rd quarter worth $307,000. Palumbo Wealth Management LLC acquired a new stake in ProShares Ultra Nasdaq Biotechnology during the 3rd quarter worth $766,000. Finally, Franklin Resources Inc. acquired a new stake in ProShares Ultra Nasdaq Biotechnology during the 2nd quarter worth $32,000.
ProShares Ultra Nasdaq Biotechnology Company Profile
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.
Further Reading
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
